Navigation Links
Mobile Tour to Provide Prescription Help to the Uninsured in Charleston, S.C.
Date:10/16/2009

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- The Post and Courier recently reported that the "Help is Here Express" bus tour visited the Piggly Wiggly at 445 Meeting Street in Charleston to help the uninsured and financially struggling learn about programs that provide free or nearly free prescription medications.

The tour is part of the Partnership for Prescription Assistance, a nationwide effort sponsored by pharmaceutical research companies to raise awareness of patient assistance programs. Visitors can also learn about medicines in development to fight chronic illnesses.

The bus, sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA), travels around the country helping people get information about programs that offer prescription assistance.

Jeff Gilbert, a spokesman for PhRMA, said there are about 475 patient assistance programs designed to help people get the medicines they need for free or nearly free. Gilbert said about 130,000 South Carolina residents have applied for help through the program since it began in 2005.

The bus is staffed by trained specialists who can help patients access information on the patient assistance programs. Patients can also visit PPA's Web site (www.pparx.org) or call the toll-free phone number: 1-888-4PPA-NOW.

Here is a link to the full story from the Post and Courier.

SOURCE Pharmaceutical Research and Manufacturers of America


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive
2. New Orggit iPhone Application Provides Mobile Access to Important Documents, Medical Information and Personal Data
3. Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations
4. Envisionier Announces the Launch of the endogo(R) HD, a Mobile Medical Imaging Platform for Capturing, Storing, and Sharing Endoscopic Multimedia
5. Midwest Mobile Dog Heart Health Tour to Provide Free Heart Examinations
6. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
7. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
8. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
9. Young Innovations, Inc. Provides Third Quarter Conference Call Details
10. MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples
11. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 1New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 2New Certification Commission for Healthcare Interpreters Opens Doors to Improve Provider Patient Communication 26 Quality Medical Care 57223 3Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 1Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 2Biosimilars of Rituxan MabThera Herceptin and Erbitux will Erode 248 2 Billion in U S and European Sales in 2018 57220 3People With Swine Flu May Be Contagious Longer Than Thought 57217 1People With Swine Flu May Be Contagious Longer Than Thought 57217 2People With Swine Flu May Be Contagious Longer Than Thought 57217 3